Samsung Bioepis Responds To Rumor Of Biogen Biosimilars Buyout

Korean Media Suggests Former Partner Could Acquire Remaining Biosimilars Business

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.